<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26936" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Percutaneous Transluminal Coronary Angioplasty</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malik</surname>
            <given-names>Talia F.</given-names>
          </name>
          <aff>Chicago Medical School at Rosalind Franklin University of Medicine and Science</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tivakaran</surname>
            <given-names>Vijai S.</given-names>
          </name>
          <aff>Kettering Health Network</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Talia Malik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vijai Tivakaran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26936.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Percutaneous transluminal coronary angioplasty (PTCA), or percutaneous coronary intervention (PCI), is a minimally invasive procedure to open blocked or stenosed coronary arteries, allowing unobstructed blood flow to the myocardium. The blockages occur because of lipid-rich plaque within the arteries, diminishing blood flow to the myocardium. The accumulation of lipid-rich plaque in the arteries is known as atherosclerosis. The disorder is known as coronary artery disease caused by atherosclerosis affecting the coronary arteries. This activity describes the indications, contraindications, and complications of PTCA and highlights the interprofessional team's role in managing patients with CAD.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for PTCA.</p></list-item><list-item><p>Assess&#x000a0;the contraindications for PTCA.</p></list-item><list-item><p>Evaluate&#x000a0;the complications of PTCA.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among the interprofessional team to enhance care delivery for patients undergoing PTCA.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26936&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26936">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26936.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Percutaneous transluminal coronary angioplasty (PTCA), or percutaneous coronary intervention (PCI), is a minimally invasive procedure to open blocked or stenosed coronary arteries, allowing unobstructed blood flow to the myocardium. The blockages occur because of lipid-rich plaque within the arteries, diminishing blood flow to the myocardium. The accumulation&#x000a0;of&#x000a0;lipid-rich&#x000a0;plaque in the arteries&#x000a0;is known as atherosclerosis. The disorder is known as coronary artery disease caused by atherosclerosis affecting the coronary arteries. Patients with CAD&#x000a0;usually present with exertional chest pain or with dyspnea with exertion. In acute myocardial infarction, there is plaque rupture with platelet aggregation and&#x000a0;acute thrombus formation, which results in a sudden occlusion of the&#x000a0;coronary artery. These patients present with acute chest heaviness, diaphoresis, and nausea. Urgent PTCA is often required to limit myocardial damage.</p>
        <p>Andreas Gruentzig&#x000a0;first developed PCTA in 1977, and the procedure was performed in Zurich, Switzerland, that same year.<xref ref-type="bibr" rid="article-26936.r1">[1]</xref>&#x000a0;By the mid-1980s, many leading institutions had adopted this procedure worldwide to treat coronary artery disease. PTCA is a hallmark procedure and the basis of many other intracoronary interventions. It is&#x000a0;1 of the most common procedures in the United States, making up 3.6% of all operating room procedures performed in 2011.</p>
      </sec>
      <sec id="article-26936.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The 2, main coronary arteries supplying the heart are the right and left coronary arteries. The left coronary artery (LCA) divides into left anterior descending (LAD) and left circumflex artery (LCX) branches. LCA supplies blood to the left ventricle of the heart. See <bold>Image.</bold> Coronary&#x000a0;Angiogram&#x000a0;Showing&#x000a0;Normal&#x000a0;Epicardial&#x000a0;Left (A) and&#x000a0;Right (B)&#x000a0;Coronary&#x000a0;Arteries. The right coronary artery (RCA) divides into the&#x000a0;right posterior descending (PDA) and a (PL) posterolateral branch. RCA supplies blood to the ventricles, right atrium, and sinoatrial node. Coronary arteries are end-arteries supplying the myocardium, and blockage can lead to serious adverse effects. Coronary artery disease occurs due to plaque buildup within the coronary arteries, which reduces blood flow to the myocardium with subsequent narrowing and blockage.</p>
      </sec>
      <sec id="article-26936.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Indications of PTCA depend on various factors. Patients with stable angina symptoms unresponsive to maximal medical therapy will benefit from&#x000a0;PCI. It helps provide relief of persistent angina symptoms&#x000a0;despite maximal medical therapy.<xref ref-type="bibr" rid="article-26936.r2">[2]</xref>&#x000a0;Emergency PTCA&#x000a0;is&#x000a0;indicated&#x000a0;for acute ST-elevation myocardial infarction (STEMI), suggesting 100% occlusion of the&#x000a0;coronary artery. With acute STEMI, patients are taken directly to the cath lab immediately upon presentation to help prevent further myocardial muscle damage. In non-ST-elevation myocardial infarction (NSTEMI), or unstable angina, (known as acute coronary syndromes),&#x000a0;patients are taken to the cardiac cath lab within 24 to 48 hours.</p>
      </sec>
      <sec id="article-26936.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>PTCA has limited contraindications. Patients with left main CAD are poor candidates for the procedure due to the risk of acute obstruction or spasm of the left main coronary artery during the procedure. It is also not recommended for patients with hemodynamically insignificant (less than 70%) stenosis of the coronary arteries.</p>
      </sec>
      <sec id="article-26936.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Initially, PCI was performed using balloon catheters alone. However, other devices were introduced due to subclinical outcomes and vessel re-stenosis, including atherectomy devices and coronary stents.&#x000a0;Atherectomy devices used alone resulted in poor outcomes. Coronary stents are the most widely used intracoronary devices in PTCA due to improved clinical outcomes. Various stents are available, including traditional bare-metal (BMS) and drug-eluting (DES). DES has a polymer coating that prevents inflammation and endothelial cell proliferation. Most recent DES used in the United States use sirolimus, everolimus, and zotarolimus. The newer generation DES has reduced the incidence of late stent thrombosis.<xref ref-type="bibr" rid="article-26936.r3">[3]</xref>&#x000a0;Antiplatelet therapy is important during the first 12 months&#x000a0;after PTCA, allowing appropriate duration for endothelial cell formation over the metallic stent to prevent stent thrombosis.</p>
      </sec>
      <sec id="article-26936.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>PTCA is performed by a team consisting of an interventional cardiologist, nurse, and radiology technologist. All team members must have extensive specialized training in the procedure.</p>
      </sec>
      <sec id="article-26936.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>An interprofessional team evaluates the patients and performs pre-procedural testing to determine candidacy for the procedure. The inquiry about the history of allergy to seafood or contrast agents is vital. Important pre-procedure laboratory tests include PT and PTT, serum electrolytes, BUN, and creatinine. The patient&#x000a0;is required to be well-hydrated. Medication review is essential, including cessation of anticoagulants if possible. Also, common medications, including NSAIDs or ACEIs, can be held to prevent worsening renal insufficiency. The diabetes medication metformin is held before cardiac catheterization to avoid worsening renal insufficiency&#x000a0;and lactic acidosis.&#x000a0;Fluids and food are restricted 6 to 8 hours before the procedure. When cases are performed via radial artery access, patients are often given&#x000a0;intra-arterial calcium channel blockers, nitroglycerin, and heparin to prevent vasospasm. The health care provider should thoroughly explain the procedure and its associated risks and complications to the patient to obtain a signed informed consent.</p>
      </sec>
      <sec id="article-26936.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The procedure is performed under local anesthesia. Conscious sedation is routinely given to avoid stress and calm the patient. The most commonly used approach is the percutaneous femoral (Judkins) approach. Once the patient is&#x000a0;anesthetized&#x000a0;with a superficial injection of lidocaine to the skin and subcutaneous tissues over the right femoral artery,&#x000a0;a needle&#x000a0;is inserted into the femoral artery (percutaneous access). The insertion of a guidewire follows successful needle insertion through the needle into the lumen of the blood vessel. The needle is then&#x000a0;removed with the guidewire remaining in the vessel lumen. A sheath with an introducer is placed over the guidewire and into the femoral artery. Next, the guidewire&#x000a0;and&#x000a0;introducer are removed, leaving the sheath in the vessel lumen. This provides easy access to the femoral artery lumen. Next, a long, narrow tube, known&#x000a0;as the "diagnostic catheter," is advanced through the sheath with a long&#x000a0;guidewire in the catheter lumen. The diagnostic catheter follows the guidewire and is passed&#x000a0;retrograde through the femoral artery, iliac artery, descending aorta, and over the aortic arch to the proximal ascending aorta.&#x000a0;The guidewire is removed, leaving the diagnostic catheter's tip in the ascending aorta.&#x000a0;The diagnostic catheter&#x000a0;is attached to a manifold with a&#x000a0;syringe. The manifold allows for injecting contrast, checking inter-arterial pressure, and administering medications.</p>
        <p>The diagnostic&#x000a0;catheter&#x000a0;is then manipulated into&#x000a0;the ostium of the left main coronary artery or right coronary artery.&#x000a0;Contrast dye&#x000a0;is injected, and cineangiography&#x000a0;images are&#x000a0;obtained in multiple views of both arteries. PTCA can be performed if severe stenosis exists in 1 of the arteries. The diagnostic catheter&#x000a0;is removed and exchanged for&#x000a0;a similar guide catheter. Guide catheters have a larger luminal diameter to pass wires and balloons during angioplasty easily.&#x000a0;After the&#x000a0;guide catheter is placed in the ostium of the respective artery, a PTCA&#x000a0;guidewire&#x000a0;is advanced&#x000a0;through the catheter and across the stenosis. Once the PTCA guidewire is passed across the stenosis, it&#x000a0;is left in place until the end of the procedure.&#x000a0;A balloon wire&#x000a0;can be placed over the PTCA&#x000a0;guidewire and advanced until the balloon is directly over the stenosis. The cardiologist controls the direction and movement of the PTCA guidewire and balloon wire by twisting the part of the guidewire that sits outside the patient.</p>
        <p>The balloon is then inflated and deflated repeatedly until the artery is patent. In most instances, a stent is required. The balloon wire is removed and exchanged for a stent. A stent is a latticed metal scaffold delivered crimped over a balloon of balloon wire. The stent is then placed in the position of the stenosis, and the balloon is expanded. Once the stent is expanded, it cannot be removed from the artery.&#x000a0;The balloon&#x000a0;is deflated,&#x000a0;and the stent remains in place.&#x000a0;The&#x000a0;stent can maintain&#x000a0;long-term&#x000a0;patency.&#x000a0;Repeated injections of contrast media&#x000a0;are utilized&#x000a0;to check for artery patency. Upon successfully inserting the stent and expanding the vessel, the balloon&#x000a0;wire&#x000a0;is removed. Lastly, the PTCA guidewire is removed. During the procedure, anticoagulation&#x000a0;is administered to prevent the formation of clots. Depending upon the technical difficulties of the case, the entire procedure can take from 30 minutes to 3 hours.</p>
      </sec>
      <sec id="article-26936.s10" sec-type="Complications">
        <title>Complications</title>
        <p>PTCA is widely practiced and has risks, but major procedural complications are rare. The mortality rate during angioplasty is 1.2%.<xref ref-type="bibr" rid="article-26936.r4">[4]</xref> People older than the age of 65, with kidney disease or diabetes, women and those with massive heart disease are at a higher risk for complications. Possible complications include hematoma at the femoral artery insertion site, pseudoaneurysm of the femoral artery, infection of skin over the femoral artery, embolism, stroke, kidney injury from contrast dye, hypersensitivity to dye, vessel rupture, coronary artery dissection, bleeding, vasospasm, thrombus formation, and acute MI. There is a long-term&#x000a0;risk of re-stenosis of the stented vessel.</p>
      </sec>
      <sec id="article-26936.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>PTCA is performed under local anesthesia and serves as an alternative to coronary artery bypass surgery (CABG). Compared to CABG,&#x000a0;PTCA is associated with lower morbidity and mortality, shorter recovery, and lower cost. It can significantly improve blood flow through the coronary arteries in about 90% of patients, with relief of anginal symptoms and improvement in exercise capacity. It effectively&#x000a0;eliminates arterial narrowing in most cases. Different modeling studies presented different conclusions regarding the cost-effectiveness of PTCA and CABG in patients with myocardial ischemia who do not respond to medical therapy.<xref ref-type="bibr" rid="article-26936.r5">[5]</xref><xref ref-type="bibr" rid="article-26936.r6">[6]</xref><xref ref-type="bibr" rid="article-26936.r7">[7]</xref></p>
      </sec>
      <sec id="article-26936.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PTCA is not an easy procedure; despite technological advances, it has risks and complications. All patients need to be educated about the procedure and its potential complications. Maintaining a healthy diet, exercising, and reducing stress are important post-procedural measures to reduce the risk of recurrences and complications. The heart team illustrates an excellent example of patient-centered care. Experts from different fields of medicine come together to provide the best solution for each patient.<xref ref-type="bibr" rid="article-26936.r8">[8]</xref></p>
      </sec>
      <sec id="article-26936.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26936&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26936">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26936/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26936">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26936.s14">
        <fig id="article-26936.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Coronary Angiogram Showing Normal Epicardial Left (A) and Right (B) Coronary Arteries. Contributed by N Telles, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Fig.__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26936.s15">
        <title>References</title>
        <ref id="article-26936.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>L&#x000fc;scher</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>25 years of coronary angioplasty: almost a fairy tale.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Feb</month>
            <day>08</day>
            <volume>361</volume>
            <issue>9356</issue>
            <fpage>527</fpage>
            <pub-id pub-id-type="pmid">12583964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pursnani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Korley</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gopaul</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kanade</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Bangalore</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2012</year>
            <month>Aug</month>
            <day>01</day>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>476</fpage>
            <page-range>476-90</page-range>
            <pub-id pub-id-type="pmid">22872053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palmerini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Benedetto</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Biondi-Zoccai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Della Riva</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bacchi-Reggiani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smits</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Vlachojannis</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Berencsi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Valgimigli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orlandi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rapezzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Safety of Drug-Eluting and&#x000a0;Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Jun</month>
            <day>16</day>
            <volume>65</volume>
            <issue>23</issue>
            <fpage>2496</fpage>
            <page-range>2496-507</page-range>
            <pub-id pub-id-type="pmid">26065988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Movahed</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Hashemzadeh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamal</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ramaraj</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Decreasing in-hospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>58</fpage>
            <page-range>58-60</page-range>
            <pub-id pub-id-type="pmid">20124588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stroupe</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Barnett</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lyttle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hynes</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WG</given-names>
              </name>
              <collab>Investigators of Veterans Affairs Cooperative Studies Program #385 (AWESOME: Angina With Extremely Serious Operative Mortality Evaluation)</collab>
            </person-group>
            <article-title>Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Sep</month>
            <day>19</day>
            <volume>114</volume>
            <issue>12</issue>
            <fpage>1251</fpage>
            <page-range>1251-7</page-range>
            <pub-id pub-id-type="pmid">16966588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osnabrugge</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Magnuson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van Klaveren</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Farooq</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Abdallah</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vilain</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Steyerberg</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Morice</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Dawkins</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Kappetein</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DJ</given-names>
              </name>
              <collab>SYNTAX trial investigators</collab>
            </person-group>
            <article-title>Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.</article-title>
            <source>Heart</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>101</volume>
            <issue>24</issue>
            <fpage>1980</fpage>
            <page-range>1980-8</page-range>
            <pub-id pub-id-type="pmid">26552756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kolm</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grau-Sepulveda</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Ponirakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shahian</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Garratt</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Cost-effectiveness of revascularization strategies: the ASCERT study.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Jan</month>
            <day>06</day>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">25572503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26936.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welsh</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Westerhout</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Blankenship</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Hamm</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Van de Werf</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>PW</given-names>
              </name>
              <collab>APEX AMI Investigators</collab>
            </person-group>
            <article-title>Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-51</page-range>
            <pub-id pub-id-type="pmid">20298996</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
